the republic logo

Johnson & Johnson to pay $7.8M settlement in suit over drug's marketing to Arkansas doctors


LITTLE ROCK, Arkansas — Court filings show pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over how the company marketed an antipsychotic drug to Arkansas doctors.

The Arkansas Democrat-Gazette ( ) reports $2 million will go to a Texas law firm that represented Arkansas in the suit, which began more than seven years ago.

A Pulaski County jury ruled three years ago that the company, through its Janssen Pharmaceutical subsidiary, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was imposed on Johnson & Johnson, but it was later overturned by the Arkansas Supreme Court.

Janssen representative Michelle Bauer said Monday that the settlement isn't an admission of liability.

Information from: Arkansas Democrat-Gazette,

Think your friends should see this? Share it with them!

Story copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Feedback, Corrections and Other Requests: AP welcomes feedback and comments from readers. Send an email to and it will be forwarded to the appropriate editor or reporter.

We also have more stories about:
(click the phrases to see a list)


Follow The Republic:

All content copyright ©2015 The Republic, a division of Home News Enterprises unless otherwise noted.
All rights reserved. Privacy policy.